SCHEMBL2669868

SCHEMBL2669868

Cc1nc(NC(=O)c2cc(Oc3ccc(P(=O)(O)N=O)cc3)cc(OC(C)C)c2)sc1C(C)(C)C#N

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 18/20 0.46
▸ KCNH2 Q12809 3/20 0.38
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12021541 0.85 GCK (0.51) GCKKCNH2TP53
SCHEMBL12021481 0.80 GCK (0.55) GCKKCNH2
SCHEMBL12021355 0.78 GCK (0.52) GCKKCNH2
SCHEMBL12021520 0.73 GCK (0.52) GCKKCNH2TP53
SCHEMBL12021513 0.73 GCK (0.49) GCKTP53
SCHEMBL12021311 0.72 GCK (0.60) GCKKCNH2
SCHEMBL12021296 0.72 GCK (0.52) GCK
SCHEMBL12021247 0.72 GCK (0.75) GCK
SCHEMBL12021320 0.72 NPC1 (0.53) GCK
SCHEMBL16674415 0.72 GCK (0.49) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009023718-A2 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS, INC. (US) 2009-02-19 — — WO disclosed
Send feedback